GREENFIELD, Ind.--(BUSINESS WIRE)-- Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzinâ„¢-CA1 (molidustat oral suspension), conditionally approved by ...
(RTTNews) - The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It ...
SILVER SPRING, Md. , May 1, 2023 /PRNewswire/ --Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results